The influence of various storage conditions on cell viability in amniotic membrane

被引：80
作者：
Hennerbichler S. [1 ,3 ,4 ]
Reichl B. [1 ,3 ]
Pleiner D. [1 ]
Gabriel C. [2 ]
Eibl J. [3 ]
Redl H. [1 ]
机构：
[1] Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Linz-Viena
[2] Red Cross Transfusion Service of Upper Austria, Linz
[3] Bio-Products and Bio-Engineering AG, Vienna
[4] 4020 Linz-Viena
来源：
Cell and Tissue Banking | 2007年 / 8卷 / 1期
关键词：
Amniotic membrane; Cell viability; EZ4U; L15; Preservation;
D O I：
10.1007/s10561-006-9002-3
中图分类号：
学科分类号：
摘要：
Up to now freeze-dried, gamma-sterilised or glycerol-preserved amniotic membranes (AMs) have widely been used in the field of ophthalmology and wound care (e.g. leg ulcers, burns). After some preservation processes in use, like freeze-drying or glycerol-preserving, the cells in the AM are no longer viable. Within this study we evaluated the influence of different short-term and long-term storage conditions on cell viability in AM. Therefore AMs from cesarean section placentae were washed and biopsied to evaluate the microbiological status and to determine the viability of the tissue. Additionally, viability under various storage conditions was examined by assessment of mitochondrial activity. Preservation included temperatures above and below 0°C as well as various media compositions. As expected, cell viability in amnion decreases during storage, in fact the effect was more pronounced when stored frozen, but the higher viability of amnion obtained by storage above 0°C with medium is associated with the limitation to a short period of storage of about 28 days. The evaluated preservation methods are the basis for future non-clinical in-vivo studies in which the possible benefit of amnion as a viable biomaterial in wound healing will be investigated. © Springer Science+Business Media B.V. 2006.
引用
收藏
页码：1 / 8
页数：7
相关论文
共 52 条
  • [1] Adinolfi M., Akle C.A., McColl I., Fensom A.H., Tansley L., Connolly P., Hsi B.L., Faulk W.P., Travers P., Bodmer W.F., Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells, Nature, 295, pp. 325-327, (1982)
  • [2] Akle C.A., Adinolfi M., Welsh K.I., Leibowitz S., McColl I., Immunogenicity of human amniotic epithelial cells after transplantation into volunteers, Lancet, 2, pp. 1003-1005, (1981)
  • [3] Arora M., Jaroudi K.A., Hamilton C.J., Dayel F., Controlled comparison of interceed and amniotic membrane graft in the prevention of postoperative adhesions in the rabbit uterine horn model, Eur J Obstet Gynecol Reprod Biol, 55, pp. 179-182, (1994)
  • [4] Burger K., Artificial vagina reconstruction with the help of amnion, Zentralblatt Für Gynükol, pp. 2437-2440, (1937)
  • [5] Burgos H., Faulk W.P., The maintenance of human amniotic membranes in culture, Br J Obstet Gynaecol, 88, pp. 294-300, (1981)
  • [6] Davis J.W., Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital, Johns Hopkins Med J, 15, pp. 307-396, (1910)
  • [7] de Rotth A., Plastic repair of conjunctival defects with fetal membranes, Arch Ophthalmol, 23, pp. 522-525, (1940)
  • [8] Dhall K., Amnion graft for treatment of congenital absence of the vagina, Br J Obstet Gynaecol, 91, pp. 279-282, (1984)
  • [9] Dohrmann P., Fory R., Rupp K., Hamelmann H., Animal experiment studies of amnion transplantation as peritoneal replacement, Langenbecks Arch Chir Suppl, 2, pp. 1055-1059, (1990)
  • [10] Dua H.S., Azuara-Blanco A., Amniotic membrane transplantation, Br J Ophthalmol, 83, pp. 748-752, (1999)
123456